AI-Selected Medtech Leader Rockets Higher After Major U.S. Supply Deal; Stock Up Nearly 92% Since Pick
August’s earnings season has produced pronounced stock-specific rallies even as indices showed intermittent weakness. Professional model-driven pick lists uncovered a string of winners, led by Haemonetics Corporation (NYSE:HAE), which surged 15.9% on news of a U.S. supply agreement with CSL Plasma. That rally builds on outsized profitability, recen…